Replimune REPL
NASDAQ REPL
$11.95 +0.53 (+4.64%)
As of: Oct 21, 2026 · 11:41 AM EDT

Replimune (REPL) Long-Term Debt Issuances (2023)

Updated

Replimune's Long-Term Debt Issuances came in at $35 million for FY2026 (year ended Mar 31, 2026).

Analysis

Replimune (REPL) Long-Term Debt Issuances (2023) Analysis & Trends

Going back to FY2020, Replimune's Long-Term Debt Issuances data covers 4 fiscal years.

  • Long-Term Debt Issuances carries a three-year compound annual growth rate of 7.5% (FY2023 to FY2026).
  • Per Business Quant, earlier fiscal years put Long-Term Debt Issuances at $15 million in FY2024 (-46.7%) and $28.15 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Replimune 1.15 Bn 96.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -1.85 Mn
API Access

Replimune Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=REPL&period=max&api_key=YOUR_API_KEY